SCHEMBL30095195

SCHEMBL30095195

CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(=O)(=O)c2ccc(F)cc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 14/20 0.84
▸ CYP1A2 P05177 3/20 0.83
▸ MAPT P10636 3/20 0.83
▸ MAPK1 P28482 3/20 0.83
▸ TDP1 Q9NUW8 2/20 0.83
▸ CYP3A4 P08684 2/20 0.83
▸ PMP22 Q01453 2/20 0.83
▸ NPSR1 Q6W5P4 2/20 0.83
▸ GLA P06280 1/20 0.83
▸ TSHR P16473 1/20 0.83
▸ EDNRA P25101 1/20 0.83
▸ HIF1A Q16665 1/20 0.83
▸ HSD17B10 Q99714 1/20 0.83
▸ RXRA P19793 6/20 0.74
▸ PTGS2 P35354 2/20 0.71
▸ EGFR P00533 1/20 0.71
▸ ADORA3 P0DMS8 1/20 0.71
▸ DRD1 P21728 1/20 0.71
▸ PTGS1 P23219 1/20 0.71
▸ OPRM1 P35372 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24101477 1.00 PPARG (0.84) PPARGCYP1A2MAPTMAPK1TDP1
SCHEMBL30913371 0.92 CYP1A2 (0.74) PPARGCYP1A2MAPTMAPK1TDP1
Exisulind SCHEMBL25371 0.91 CYP1A2 (1.00) PPARGCYP1A2MAPTMAPK1TDP1
Exisulind SCHEMBL1651133 0.91 CYP1A2 (1.00) PPARGCYP1A2MAPTMAPK1TDP1
Exisulind SCHEMBL29395528 0.91 CYP1A2 (1.00) PPARGCYP1A2MAPTMAPK1TDP1
Exisulind SCHEMBL4776597 0.91 CYP1A2 (1.00) PPARGCYP1A2MAPTMAPK1TDP1
SCHEMBL30913530 0.91 PPARG (0.74) PPARGCYP1A2MAPTMAPK1TDP1
Exisulind SCHEMBL9711060 0.90 CYP1A2 (0.98) PPARGCYP1A2MAPTMAPK1TDP1
SCHEMBL8521006 0.90 CYP1A2 (0.82) PPARGCYP1A2MAPTMAPK1TDP1
Exisulind SCHEMBL7634644 0.90 CYP1A2 (0.98) PPARGCYP1A2MAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619369-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS Nucmito Pharmaceuticals Co., Ltd. (CN) 2025-09-24 — — EP claimed
WO-2024104384-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS NUCMITO PHARMACEUTICALS CO. LTD. (CN) 2024-05-23 — — WO claimed
CN-116472034-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2023-07-21 — — CN claimed
EP-4165009-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS Nucmito Pharmaceuticals Co., Ltd. (CN) 2023-04-19 — — EP claimed
EP-4619369-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS Nucmito Pharmaceuticals Co., Ltd. (CN) 2025-09-24 — — EP disclosed
WO-2024104384-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS NUCMITO PHARMACEUTICALS CO. LTD. (CN) 2024-05-23 — — WO disclosed
CN-117916215-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2024-04-19 — — CN disclosed
EP-4337628-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS Nucmito Pharmaceuticals Company Limited (CN) 2024-03-20 — — EP disclosed
CN-116472034-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2023-07-21 — — CN disclosed
EP-4165009-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS Nucmito Pharmaceuticals Co., Ltd. (CN) 2023-04-19 — — EP disclosed
WO-2022242582-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS NUCMITO PHARMACEUTICALS COMPANY LIMITED (CN) 2022-11-24 — — WO disclosed
Send feedback